Camber Capital Management's stake in NuVasive totals $79.7M: 3 points

Spinal Tech

Camber Capital Management bought 400,000 NuVasive shares during the most recent quarter, according to a The Market Digest report.

Here are three points:

 

1. The investment management firm now holds a total of 1.5 million NuVasive shares, valued at $79.7 million.

 

2. NuVasive reported total revenue of $215.1 million in first quarter of 2016, an 11.8 percent increase from the $192.4 million reported for the first quarter of 2015.

 

3. The company's net loss reached $8.9 million for the first quarter 2016.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers